Literature DB >> 24523409

Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.

Katja Jehle1, Laura Cato, Antje Neeb, Claudia Muhle-Goll, Nicole Jung, Emmanuel W Smith, Victor Buzon, Laia R Carbó, Eva Estébanez-Perpiñá, Katja Schmitz, Ljiljana Fruk, Burkhard Luy, Yu Chen, Marc B Cox, Stefan Bräse, Myles Brown, Andrew C B Cato.   

Abstract

The androgen receptor (AR) is a ligand-activated transcription factor that is essential for prostate cancer development. It is activated by androgens through its ligand-binding domain (LBD), which consists predominantly of 11 α-helices. Upon ligand binding, the last helix is reorganized to an agonist conformation termed activator function-2 (AF-2) for coactivator binding. Several coactivators bind to the AF-2 pocket through conserved LXXLL or FXXLF sequences to enhance the activity of the receptor. Recently, a small compound-binding surface adjacent to AF-2 has been identified as an allosteric modulator of the AF-2 activity and is termed binding function-3 (BF-3). However, the role of BF-3 in vivo is currently unknown, and little is understood about what proteins can bind to it. Here we demonstrate that a duplicated GARRPR motif at the N terminus of the cochaperone Bag-1L functions through the BF-3 pocket. These findings are supported by the fact that a selective BF-3 inhibitor or mutations within the BF-3 pocket abolish the interaction between the GARRPR motif(s) and the BF-3. Conversely, amino acid exchanges in the two GARRPR motifs of Bag-1L can impair the interaction between Bag-1L and AR without altering the ability of Bag-1L to bind to chromatin. Furthermore, the mutant Bag-1L increases androgen-dependent activation of a subset of AR targets in a genome-wide transcriptome analysis, demonstrating a repressive function of the GARRPR/BF-3 interaction. We have therefore identified GARRPR as a novel BF-3 regulatory sequence important for fine-tuning the activity of the AR.

Entities:  

Keywords:  Activation Function-2 (AF-2); Androgen Receptor; Androgen Receptor Ligand-binding Domain (AR-LBD); Bag-1L; Binding Function-3 (BF-3); Chromatin Immunoprecipitation (ChiP); Gene Expression; Ligand-binding Protein; Nuclear Receptors; Prostate Cancer

Mesh:

Substances:

Year:  2014        PMID: 24523409      PMCID: PMC3979403          DOI: 10.1074/jbc.M113.534859

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  Functional analysis of 44 mutant androgen receptors from human prostate cancer.

Authors:  Xu-Bao Shi; Ai-Hong Ma; Liang Xia; Hsing-Jien Kung; Ralph W de Vere White
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

2.  Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control.

Authors:  Valerie Christiaens; Charlotte L Bevan; Leen Callewaert; Anna Haelens; Guy Verrijdt; Wilfried Rombauts; Frank Claessens
Journal:  J Biol Chem       Date:  2002-10-04       Impact factor: 5.157

3.  The cochaperone Bag-1L enhances androgen receptor action via interaction with the NH2-terminal region of the receptor.

Authors:  Liubov Shatkina; Sigrun Mink; Hermann Rogatsch; Helmut Klocker; Gernot Langer; Andrea Nestl; Andrew C B Cato
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

4.  Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis.

Authors:  Yukio Takeshita; Ryutaro Fujinaga; Changjiu Zhao; Akie Yanai; Koh Shinoda
Journal:  Hum Mol Genet       Date:  2006-06-16       Impact factor: 6.150

Review 5.  Chromatin binding by the androgen receptor in prostate cancer.

Authors:  Harri Itkonen; Ian G Mills
Journal:  Mol Cell Endocrinol       Date:  2011-10-02       Impact factor: 4.102

6.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

7.  FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.

Authors:  B He; J A Kemppainen; E M Wilson
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

8.  The hsp70-associating protein Hap46 binds to DNA and stimulates transcription.

Authors:  M Zeiner; Y Niyaz; U Gehring
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

9.  Allosteric conversation in the androgen receptor ligand-binding domain surfaces.

Authors:  Solène Grosdidier; Laia R Carbó; Víctor Buzón; Greg Brooke; Phuong Nguyen; John D Baxter; Charlotte Bevan; Paul Webb; Eva Estébanez-Perpiñá; Juan Fernández-Recio
Journal:  Mol Endocrinol       Date:  2012-05-31

10.  Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines.

Authors:  S Takayama; S Krajewski; M Krajewska; S Kitada; J M Zapata; K Kochel; D Knee; D Scudiero; G Tudor; G J Miller; T Miyashita; M Yamada; J C Reed
Journal:  Cancer Res       Date:  1998-07-15       Impact factor: 12.701

View more
  17 in total

1.  ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.

Authors:  Laura Cato; Jonas de Tribolet-Hardy; Irene Lee; Jaice T Rottenberg; Ilsa Coleman; Diana Melchers; René Houtman; Tengfei Xiao; Wei Li; Takuma Uo; Shihua Sun; Nane C Kuznik; Bettina Göppert; Fatma Ozgun; Martin E van Royen; Adriaan B Houtsmuller; Raga Vadhi; Prakash K Rao; Lewyn Li; Steven P Balk; Robert B Den; Bruce J Trock; R Jeffrey Karnes; Robert B Jenkins; Eric A Klein; Elai Davicioni; Friederike J Gruhl; Henry W Long; X Shirley Liu; Andrew C B Cato; Nathan A Lack; Peter S Nelson; Stephen R Plymate; Anna C Groner; Myles Brown
Journal:  Cancer Cell       Date:  2019-02-14       Impact factor: 31.743

2.  TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.

Authors:  Anna C Groner; Laura Cato; Jonas de Tribolet-Hardy; Tiziano Bernasocchi; Hana Janouskova; Diana Melchers; René Houtman; Andrew C B Cato; Patrick Tschopp; Lei Gu; Andrea Corsinotti; Qing Zhong; Christian Fankhauser; Christine Fritz; Cédric Poyet; Ulrich Wagner; Tiannan Guo; Ruedi Aebersold; Levi A Garraway; Peter J Wild; Jean-Philippe Theurillat; Myles Brown
Journal:  Cancer Cell       Date:  2016-05-26       Impact factor: 31.743

3.  Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation.

Authors:  Nada Lallous; Eric Leblanc; Ravi S N Munuganti; Mohamed D H Hassona; Nader Al Nakouzi; Shannon Awrey; Helene Morin; Mani Roshan-Moniri; Kriti Singh; Sam Lawn; Takeshi Yamazaki; Hans H Adomat; Christophe Andre; Mads Daugaard; Robert N Young; Emma S Tomlinson Guns; Paul S Rennie; Artem Cherkasov
Journal:  Mol Cancer Ther       Date:  2016-10-07       Impact factor: 6.261

4.  Epigenetic Coregulation of Androgen Receptor Signaling.

Authors:  Rayzel C Fernandes; Damien A Leach; Charlotte L Bevan
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  New Sites for Old Suspects: Environmental Allosteric Modifiers of Nuclear Hormone Receptors.

Authors:  Bk Asare; Rv Rajnarayanan
Journal:  J Pharmacol Clin Toxicol       Date:  2015-01-17

6.  The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling.

Authors:  Cheryl Storer Samaniego; Ji Ho Suh; Arundhati Chattopadhyay; Karen Olivares; Naihsuan Guy; Jeffrey C Sivils; Prasenjit Dey; Fumiaki Yumoto; Robert J Fletterick; Anders M Strom; Jan-Åke Gustafsson; Paul Webb; Marc B Cox
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

7.  Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.

Authors:  Greg N Brooke; Simon C Gamble; Michael A Hough; Shajna Begum; D Alwyn Dart; Michael Odontiadis; Sue M Powell; Flavia M Fioretti; Rosie A Bryan; Jonathan Waxman; Robin Wait; Charlotte L Bevan
Journal:  Mol Cell Proteomics       Date:  2015-02-18       Impact factor: 5.911

Review 8.  Control of steroid receptor dynamics and function by genomic actions of the cochaperones p23 and Bag-1L.

Authors:  Laura Cato; Antje Neeb; Myles Brown; Andrew C B Cato
Journal:  Nucl Recept Signal       Date:  2014-11-04

9.  Similarities and Distinctions in Actions of Surface-Directed and Classic Androgen Receptor Antagonists.

Authors:  Ji Ho Suh; Arundhati Chattopadhyay; Douglas H Sieglaff; Cheryl Storer Samaniego; Marc B Cox; Paul Webb
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

Review 10.  Targeting the androgen receptor with steroid conjugates.

Authors:  Paul M Levine; Michael J Garabedian; Kent Kirshenbaum
Journal:  J Med Chem       Date:  2014-07-08       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.